New study tests if extra lymph node removal boosts survival in rare kidney cancer
NCT ID NCT07321210
First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study looks at whether removing nearby lymph nodes during standard surgery for a rare kidney and ureter cancer (upper tract urothelial carcinoma) helps prevent the cancer from coming back. About 150 adults with high-risk cancer will be randomly assigned to get either the standard surgery alone or with lymph node removal. Researchers will track their health for up to 10 years to compare survival and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Second Hospital
RECRUITINGTianjin, Tianjin Municipality, 300211, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.